Vascular Biogenics Ltd (VBLT) PT Raised to $3 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Kevin DeGeeter raised the price target on Vascular Biogenics Ltd (NASDAQ: VBLT) to $3.00 (from $2.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
